Perspective treatments for triple-negative breast cancer
Date
2017-01-01
Journal Title
Journal ISSN
Volume Title
Publisher
Solen
Abstract
Description
Subject(s)
triple negative breast carcinoma, platinum derivates, olaparib, bevacizumab, eribulin, pembrolizumab.
Citation
Item identifier
ISSN
1802-4475